FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313424348> ?p ?o ?g. }

• W4313424348 abstract "Abstract Currently, cancer is the most grieving threat to society. The cancer‐related death rate has had an ascending trend, despite the implementation of numerous treatment strategies or the discovery of an array of potent molecules against several pathways of cancer growth. The need of the hour is to prevent the multidrug resistance toll, and the current efforts have been bestowed upon a versatile small molecule scaffold, coumarin (benz[α]pyrone), a natural compound possessing interesting affinity toward the cancer target human carbonic anhydrase (hCA), focusing on hCA I, II, IX, and XII. Along with coumarin, the age‐old known antibacterial drug sulfonamide, when conjugated at positions 3, 7, and 8 of coumarin either with a linker group or as a single entity, has been reported to enhance the affinity of coumarin toward the overexpressed enzymes in tumor cell lines. The sulfonamides have been listed as obsolete drugs due to the severe side effects caused by them; however, their affinity toward the hCA‐zinc–binding core has attracted the attention of researchers. Hence, in the process of drug development, coumarin and sulfonamides have remained the choice of last resort. To unveil the synthetic strategy of coumarin‐sulfonamide conjugation, their rationale for inhibiting cancer cells/enzymes, and their affinity toward various types of carcinoma have been the sole goal of the researchers. This review specifically focuses on the mechanism of action and the structure–activity relationship through synthetic strategies and the binding affinity of coumaryl‐sulfonamide conjugates with the anticancer targets possessing the highest enzyme affinity, since 2008." @default.
• W4313424348 created "2023-01-06" @default.
• W4313424348 creator A5013173650 @default.
• W4313424348 creator A5018830825 @default.
• W4313424348 creator A5038598633 @default.
• W4313424348 creator A5050105976 @default.
• W4313424348 creator A5061368317 @default.
• W4313424348 creator A5073495622 @default.
• W4313424348 date "2023-01-01" @default.
• W4313424348 modified "2023-09-26" @default.
• W4313424348 title "Coumaryl‐sulfonamide moiety: Unraveling their synthetic strategy and specificity toward <i>h</i> CA IX/XII, facilitating anticancer drug development" @default.
• W4313424348 cites W1931705150 @default.
• W4313424348 cites W1935517563 @default.
• W4313424348 cites W1970537251 @default.
• W4313424348 cites W1974196451 @default.
• W4313424348 cites W1975701262 @default.
• W4313424348 cites W1977128294 @default.
• W4313424348 cites W1978582271 @default.
• W4313424348 cites W1988812376 @default.
• W4313424348 cites W1989250669 @default.
• W4313424348 cites W1992534600 @default.
• W4313424348 cites W1994324616 @default.
• W4313424348 cites W2006350161 @default.
• W4313424348 cites W2020681885 @default.
• W4313424348 cites W2023144297 @default.
• W4313424348 cites W2023263673 @default.
• W4313424348 cites W2025766128 @default.
• W4313424348 cites W2029953509 @default.
• W4313424348 cites W2033287759 @default.
• W4313424348 cites W2033618667 @default.
• W4313424348 cites W2035795009 @default.
• W4313424348 cites W2047178318 @default.
• W4313424348 cites W2051025941 @default.
• W4313424348 cites W2051244212 @default.
• W4313424348 cites W2076803010 @default.
• W4313424348 cites W2089687855 @default.
• W4313424348 cites W2105905422 @default.
• W4313424348 cites W2120294346 @default.
• W4313424348 cites W2127285450 @default.
• W4313424348 cites W2140191908 @default.
• W4313424348 cites W2162915220 @default.
• W4313424348 cites W2169128564 @default.
• W4313424348 cites W2172242534 @default.
• W4313424348 cites W2175749292 @default.
• W4313424348 cites W2177756337 @default.
• W4313424348 cites W2325835430 @default.
• W4313424348 cites W2343737596 @default.
• W4313424348 cites W2422039834 @default.
• W4313424348 cites W2517527034 @default.
• W4313424348 cites W2531127385 @default.
• W4313424348 cites W2595278577 @default.
• W4313424348 cites W2605809496 @default.
• W4313424348 cites W2624837801 @default.
• W4313424348 cites W2725742700 @default.
• W4313424348 cites W2753810456 @default.
• W4313424348 cites W2771325009 @default.
• W4313424348 cites W2796474880 @default.
• W4313424348 cites W2797246868 @default.
• W4313424348 cites W2799983001 @default.
• W4313424348 cites W2803486635 @default.
• W4313424348 cites W2804089639 @default.
• W4313424348 cites W2805291215 @default.
• W4313424348 cites W2811066730 @default.
• W4313424348 cites W2886876983 @default.
• W4313424348 cites W2892573863 @default.
• W4313424348 cites W2901960265 @default.
• W4313424348 cites W2913917982 @default.
• W4313424348 cites W2921390335 @default.
• W4313424348 cites W2950266546 @default.
• W4313424348 cites W2967937646 @default.
• W4313424348 cites W2973099244 @default.
• W4313424348 cites W2973557793 @default.
• W4313424348 cites W2993170270 @default.
• W4313424348 cites W3011106555 @default.
• W4313424348 cites W3014500359 @default.
• W4313424348 cites W3019322471 @default.
• W4313424348 cites W3032768757 @default.
• W4313424348 cites W3033841507 @default.
• W4313424348 cites W3039236515 @default.
• W4313424348 cites W3090601841 @default.
• W4313424348 cites W3113194914 @default.
• W4313424348 cites W3128404694 @default.
• W4313424348 cites W3128646645 @default.
• W4313424348 cites W3138032798 @default.
• W4313424348 cites W3159233061 @default.
• W4313424348 cites W3171025735 @default.
• W4313424348 cites W3183941090 @default.
• W4313424348 cites W3197985339 @default.
• W4313424348 cites W3208762351 @default.
• W4313424348 cites W3214837097 @default.
• W4313424348 cites W331349755 @default.
• W4313424348 cites W4206995293 @default.
• W4313424348 cites W4213303553 @default.
• W4313424348 cites W4220785337 @default.
• W4313424348 cites W4224223896 @default.
• W4313424348 cites W4224245203 @default.
• W4313424348 cites W4252648286 @default.
• W4313424348 cites W4281870802 @default.
• W4313424348 cites W4285403779 @default.
• W4313424348 cites W4296458229 @default.

• next